http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MX-2020000690-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0f9533575751b2321d1ec25271480dc9
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-497
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4965
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D241-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D407-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D241-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495
filingDate 2018-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bc4e231803e5b0a10c089bef1a19ff8e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_443473d0c9ff1a96e4ad2ccf5d44e4a7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bbc29f54ee78418b6548becec413d970
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4a41dfe2f57022d1ded3004129c865dc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b3898e994fecb4195502928b583001f7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_54f0b350a31be70bfacb755173792e94
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a675b445af983ee0ef122a7c8a0841fa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4ae7cd65c9385442ed9770edd802c251
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d2abb2e0dcf8890351708c9f29ad83e2
publicationDate 2020-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber MX-2020000690-A
titleOfInvention HETEROCYCLIC COMPOUNDS AS ADENOSINE ANTAGONISTS.
abstract Aminopyrazine compounds are provided as modulators of an adenosine receptor; The compounds may find use as therapeutic agents for the treatment of diseases mediated through a G protein-coupled receptor signaling pathway, and may find particular use in oncology.
priorityDate 2017-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID78747
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421355198

Total number of triples: 38.